Jocelynne McRae

Jocelynne McRae

Auto-generated profile, based on publicly available information

Jocelynne McRae

National Centre for Immunisation Research and Surveillance

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2023 in Medical Journal of Australia
Verified
Journal Article
Closed access
JMJocelynne E McRae
Jocelynne E McRae
LMLisa McHugh
Lisa McHugh
CKCatherine King
Catherine King
FBFrank Beard
Frank Beard
CBChristopher Charles Blyth
Christopher Charles Blyth
KMKristine Macartney
Kristine Macartney
Summary: Vaccination in pregnancy is the best strategy to reduce complications from influenza or pertussis infection in infants who are too young to be protected directly from vaccination. Pregnant women are also at risk of influenza complications preventable through antenatal vaccination. Both vaccines are funded under the National Immunisation Program for pregnant women in Australia, but coverage is not routinely reported nationally. We reviewed all reported Australian maternal influenza and pertussis vaccine coverage data for the period 2016–2021, to identify gaps and information needs. Maternal influenza vaccine coverage was suboptimal at < 58% for 2016–2018, with higher coverage of 62–75% reported in two states (Victoria and Western Australia) for 2019–2021. Maternal pertussis vaccine coverage from 2016 was generally higher than for influenza at > 70%, with the highest jurisdictional coverage of 89% reported in Western Australia in 2020. Vaccination rates were often suboptimal among First Nations pregnant women and up to 20% lower than among non‐First Nations Australian women; while data were limited, coverage was low among culturally and linguistically diverse women and among women of lower socio‐economic status. Jurisdictional perinatal data collections were the best source of information on antenatal vaccine coverage but were only available for a minority of the population; a nationally consistent systematic approach is lacking. Timely and comprehensive data are needed to provide feedback to improve maternal vaccination coverage, particularly among groups with higher risk and/or low uptake, and as new vaccines are recommended, including COVID‐19 vaccination.

15 June 2022 in Public Health Research and Practice
Verified
Journal Article
Open access
JMJocelynne McRae
Jocelynne McRae
ADAditi Dey
Aditi Dey
SCSamantha Carlson
Samantha Carlson
JSJohn Sinn
John Sinn
PMPeter McIntyre
Peter McIntyre
NWNicholas Wood
Nicholas Wood
Objective: Pregnant women are recognised as being at risk of serious illness from influenza. Despite this, and longstanding national recommendations for vaccination in pregnancy, vaccine uptake remains suboptimal. This study aims to determine factors associated with women declining influenza vaccination in pregnancy. Method: We surveyed pregnant women from antenatal clinics at two Sydney hospitals as part of an evaluation of the New South Wales (NSW) Health 2017 influenza vaccination in pregnancy campaign. Factors associated with a woman’s decision to decline influenza vaccination were assessed using Pearson’s chi-square test and multivariable logistic regression. Results: Among 642 women surveyed, 58% self-reported influenza vaccination during pregnancy and 19% reported they had declined vaccination. Factors associated with a decision to decline vaccination included lack of a recommendation from a maternity care provider (adjusted odds ratio [aOR] 6.06; 95% confidence interval [CI] 3.50, 10.50), recommendation against vaccination (aOR 4.17; 95% CI 2.07, 8.38), having never previously been vaccinated for influenza (aOR 2.75; 95% CI 1.64, 4.59) and, among third-trimester women, not having been vaccinated for pertussis (aOR 2.55; 95% CI 1.32, 4.89). On univariate analyses, women who declined vaccination were more likely to disagree or feel uncertain about vaccine safety or effectiveness compared with women who chose to be vaccinated. Conclusion: Recommendations from maternity care providers remain key to a woman’s decision to be vaccinated for influenza during pregnancy. Time should be allocated for vaccine discussions early in pregnancy as part of routine care. Continued efforts are needed to improve messaging to pregnant women on the benefits, safety and efficacy of influenza vaccination.

29 March 2022 in Vaccine
Verified
Journal Article
Closed access
JMJ. McRae
J. McRae
CBChristopher Charles Blyth
Christopher Charles Blyth
ACA.C. Cheng
A.C. Cheng
HQH.E. Quinn
H.E. Quinn
NWN. Wood
N. Wood
KMK.K. Macartney
K.K. Macartney

1 September 2017 in Communicable Diseases Intelligence
Verified
Journal Article
Open access
PDF file
JMJocelynne E McRae
Jocelynne E McRae
HQHelen E Quinn
Helen E Quinn
KMKristine Macartney
Kristine Macartney
Introduction: The Paediatric Active Enhanced Disease Surveillance (PAEDS) network is a hospital-based active surveillance system employing prospective case ascertainment for selected serious childhood conditions, particularly vaccine preventable diseases and potential adverse events following immunisation (AEFI). PAEDS data is used to better understand these conditions, inform policy and practice under the National Immunisation Program, and enable rapid public health responses for certain conditions of public health importance. PAEDS enhances data available from other Australian surveillance systems by providing prospective, detailed clinical and laboratory information on children with selected conditions. This is the second of the planned annual PAEDS reporting series, and presents surveillance data for 2015.Methods: Specialist surveillance nurses screened hospital admissions, emergency department records, laboratory and other data, on a daily basis in 5 paediatric tertiary referral hospitals in New South Wales, Victoria, South Australia, Western Australia and Queensland to identify children with the selected conditions. Standardised protocols and case definitions were used across all sites. Conditions under surveillance in 2015 included acute flaccid paralysis (a syndrome associated with poliovirus infection), acute childhood encephalitis (ACE), influenza, intussusception (IS; a potential AEFI with rotavirus vaccines), pertussis and varicella-zoster virus infection (varicella and herpes zoster). Most protocols restrict eligibility to hospitalisations, ED only presentations are also included for some conditions.Results: In 2015, there were 674 cases identified across all conditions under surveillance. Key outcomes of PAEDS included: contribution to national AFP surveillance to reach WHO reporting targets; identification of signals for Mycoplasma pneumoniae and parechovirus-related outbreaks (ACE surveillance); and demonstration of high influenza activity with vaccine effectiveness (VE) analysis supportive of vaccination. Surveillance for IS remains ongoing with any identified AEFIs reported to the relevant State Health Department; varicella and herpes zoster case numbers decreased slightly from previous years in older children not eligible for catch-up. Pertussis case numbers increased in early 2015 and analysis of cases in children aged <1 year demonstrated the importance of timely childhood and maternal immunisation.Conclusions: PAEDS continues to provide unique policy-relevant data on serious paediatric conditions using hospital-based sentinel surveillance.

20 December 2021 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
PDF file
JMJocelynne E McRae
Jocelynne E McRae
CBChristopher Charles Blyth
Christopher Charles Blyth
ACAllen C Cheng
Allen C Cheng
HQHelen E Quinn
Helen E Quinn
NWNicholas J Wood
Nicholas J Wood
PIPaediatric Active Enhanced Disease Surveillance (PAEDS) and Influenza Complications Alert Network (FluCAN) Investigators
Paediatric Active Enhanced Disease Surveillance (PAEDS) and Influenza Complications Alert Network (FluCAN) Investigators

7 December 2022 in Neuroepidemiology
Verified
Journal Article
Closed access
PDF file
JBJunchao Bao
Junchao Bao
CNCarlos Nunez
Carlos Nunez
EEElizabeth Elliott
Elizabeth Elliott
NDNicole Dinsmore
Nicole Dinsmore
JMJocelynne McRae
Jocelynne McRae
OCon behalf of the PAEDS Investigators and APSU Contributors
on behalf of the PAEDS Investigators and APSU Contributors
Introduction: Acute flaccid paralysis (AFP) surveillance continues globally as part of the World Health Organization’s goal to eradicate poliomyelitis. The Australian Paediatric Surveillance Unit (APSU), Paediatric Active Enhanced Disease Surveillance (PAEDS) network, and National Enterovirus Reference Laboratory (NERL) collaborate in AFP surveillance in Australia, capturing and reviewing cases of AFP for all aetiologies in order to exclude poliovirus. We aimed to describe the AFP epidemiology in childhood over an 11 year period. Methods: Data were reported nationally by paediatricians via prospective APSU surveillance, PAEDS surveillance nurses at five tertiary paediatric hospitals and NERL from 2007 to 2017. Children aged 0–15 years with AFP were included. We combined APSU, PAEDS, and NERL datasets, analysed epidemiological trends, and described clinical features and investigations for major diagnoses. Results: Of 590 AFP-compatible cases, 49% were male; 47% were aged 0–4 years, 9% aged <1 year. Annual incidence of AFP was 1.3 cases per 100,000 children aged <15 years. Lower limb paralysis was the most frequent presenting symptom. The most frequent diagnoses were Guillain-Barre syndrome (GBS; 36%), transverse myelitis (TM; 17%), and acute disseminated encephalomyelitis (ADEM; 15%). No secular trend was seen in frequency of AFP cases nor amongst major diagnoses. Seasonality was observed with ADEM occurring more frequently in winter. We observed periods of increased AFP frequency in 2013 and 2016, coinciding with increased reporting of non-polio anterior horn cell disease (AHCD) and detection of non-polio enterovirus (NPEV). Conclusions: Estimated incidence of GBS, ADEM, and TM in Australian children was comparable with international rates. There was stable incidence of AFP in Australian children between 2007 and 2017. GBS, ADEM, and TM are the major causes of AFP. We observed clustering of cases associated with NPEV that emphasises a need for ongoing vigilance in surveillance given continue emerging infectious disease threats.